Pipeline Moves: Phase II cancer trial of Roche asset terminated, shot at further study drops
Praxis in essential tremor and Altamira in vertigo are also reviewed by Clinical Trials Arena
ByOther Diseases
Latest in
Other Diseases
Failure for Servier and Neurochlore’s autism drug, but potential remains in market
The large unmet need for a treatment for autism spectrum disorder is reflected in its diverse pipeline of drugs being…
By
Revised Covid-19 vaccine prices likely by the fall in the US but premium pricing possibility debatable
Companies with authorised Covid-19 vaccines in the US are likely to launch renegotiated prices as soon as the fall, experts…
By
Astellas awarded funding for opioid use disorder trials of ASP8062
Japan-based Astellas Pharma has received a grant from the US National Institutes of Health (NIH) unit to support two Phase…
BeiGene’s Phase III Trial of Zanubrutinib Misses Late-Stage Goals in Waldenström’s Macroglobulinemia
Beigene announced that its Phase III Trial of zanubrutinib compared to Johnson & Johnson/AbbVie’s ibrutinib did not achieve statistical significance…
By
Previously approved IDH2 inhibitor seeks label expansion in acute myeloid leukaemia
The Celgene trial was the first to demonstrate a benefit in the front-line setting for patients who are ineligible for…
By
Biogen will pursue aducanumab approval despite scepticism about the data presented
Biogen confirmed that high doses of aducanumab reduced clinical decline in its EMERGE trial.
By
Ubrogepant is shown to effectively treat migraine symptoms
A large-scale clinical study of 1,700 patients showed ubrogepant to be effective at easing pain and light or sound sensitivity…
By